Almirall (Group)

https://www.almirall.com

Almirall is a global biopharmaceutical company focused on skin health. We collaborate with scientists and healthcare professionals to address patient’s needs through science to improve their lives. Our Noble Purpose is at the core of our work: “Transform the patients' world by helping them realize their hopes and dreams for a healthy life”. We invest in differentiated and groundbreaking medical dermatology products to bring our innovative solutions to patients in need. The company, founded in 1943 and headquartered in Barcelona, is publically traded on the Spanish Stock Exchange and is a member of the IBEX 35 (ticker: ALM). Throughout its 77-year history, Almirall has retained a strong focus on the needs of patients. Currently, Almirall has a direct presence in 21 countries and strategic agreements in over 70, through 13 subsidiaries, with about 1,800 employees. Total revenues in 2019 were 908.4 million euros. *

	Start	0943-01-01 established
	Industry	pharmaceutical
	Industry 2	dermatic
	Person	Nazzi, Gianfranco (Almirall 202105– CEO before Teva Pharmaceuticals + AstraZeneca + GSK + Eli Lilly)
	Person 2	McClellan, Michael (Mike) (Teva 201711– CFO before Interim CFO before Sanofi)

	Region	Barcelona
	Country	Spain (España)
	Street	151 Ronda General Mitre
	City	08022 Barcelona
	Tel	+34-932-913-000
		Address record changed: 2020-12-02

Basic data	Employees	F: 1,001 to 5,000 (2021-02-03)
	Currency	EUR
	Annual sales	908,400,000 (revenues, total, consolidated (2019) 2019-12-31)
	Profit	106,000,000 (2019-12-31)
	Cash	117,400,000 (2019-12-31)

		* Document for »About Section«: Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO".

		Record changed: 2023-07-10